TrialCancer medicine2023

Efficacy and safety of fruquintinib dose-escalation strategy for elderly patients with refractory metastatic colorectal cancer: A single-arm, multicenter, phase II study.

Sirui Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.